Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesPractice ManagementMisinformation may be driving underuse of lung cancer screeningMisinformation about the harms of CT lung cancer screening may cause eligible patients to forego or not be offered the exams.Ultrasound2023 version of AASLD improves ultrasound HCC surveillanceWomens ImagingIntegrating breast and lung cancer screening could identify LC earlierAIWhat's AI's impact on radiologist burnout?InterventionalNew angioplasty technique shows promise in ICAD patients